logo
  

Sartorius To Open New Plant In Michigan In Late 2023 - Quick Facts

Sartorius AG (SDMHF.PK), a German laboratory and pharmaceutical equipment provider, announced Monday its plan to expand its presence in Michigan by opening a new 130,000-square-foot state-of-the art plant in Ann Arbor in late 2023.

The new facility will consolidate existing business operations in Washtenaw County to create a center of excellence in Ann Arbor for the Laboratory and Bioprocess Products and Services in North America.

Over three years, the project would create 160 jobs, which will include product development, operations, and other support functions.

The new plant will focus on providing innovative solutions to help customers develop drugs that cure, prevent, and halt the progression of diseases.

Sartorius said it will have an anchoring presence in the Tech Loop at the Ann Arbor Research Park and add a flagship site in North America.

For the planned expansion, the company has purchased over 15 acres of land.

Sartorius expects to more than double capacities for its key product groups by 2025.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT